Could I take your name and number, please?
cheap dutasteride Mekinist, a reversible inhibitor of MEK1 and MEK2, was approved by the US Food and Drug Administration in May, on the same day as another GSK melanoma drug Tafinlar (dabrafenib). A combination of those two treatments was granted a priority review by the FDA in September.